The U.S. Food and Drug Administration (FDA) recently released a "Letter to Health Care Providers" specifically aimed at cardiologists and electrophysiologists, among others, warning of reports of magnetic interference between breast tissue expanders with magnetic injection ports and either implantable cardioverter-defibrillators (ICDs) or pacemakers. While the Agency believes there is a very small population at risk, the alert is being issued to ensure that the problem is prevented.

Read the FDA announcement.

Clinical Topics: Arrhythmias and Clinical EP, Implantable Devices, SCD/Ventricular Arrhythmias

Keywords: Defibrillators, Implantable, Magnetics, Pacemaker, Artificial, Tissue Expansion Devices, United States Food and Drug Administration

< Back to Listings